332 related articles for article (PubMed ID: 35239092)
21. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
[TBL] [Abstract][Full Text] [Related]
22. Gentiana macrophylla flavonoids from Tibetan medicine decreases circ_0059665 to alleviate the progression of non-small cell lung cancer under hypoxia.
Ma M; Ciren D; Feng M; Zhen L; Jin G
Thorac Cancer; 2024 Jan; 15(1):77-88. PubMed ID: 37993113
[TBL] [Abstract][Full Text] [Related]
23. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
[TBL] [Abstract][Full Text] [Related]
24. Hsa_circ_0017956 Acts as miR-758-3p Sponge to Facilitate the Progression of Non-small-Cell Lung Cancer by Regulating FOXP4 Expression.
Sun C; Zhang J; Liu J; Tong J; Wang P
Mol Biotechnol; 2023 Oct; 65(10):1715-1728. PubMed ID: 36763305
[TBL] [Abstract][Full Text] [Related]
25. Circ-PGC increases the expression of FOXR2 by targeting miR-532-3p to promote the development of non-small cell lung cancer.
Xia D; Chen Z; Liu Q
Cell Cycle; 2021 Nov; 20(21):2195-2209. PubMed ID: 34494941
[TBL] [Abstract][Full Text] [Related]
26. Circ_0000003 promotes the proliferation and metastasis of non-small cell lung cancer cells via miR-338-3p/insulin receptor substrate 2.
Li S; Niu X; Li H; Liang Y; Sun Z; Yan Y
Cell Cycle; 2019 Dec; 18(24):3525-3539. PubMed ID: 31736412
[No Abstract] [Full Text] [Related]
27. Circular RNA hsa_circ_0004689 (circSWT1) promotes NSCLC progression via the miR-370-3p/SNAIL axis by inducing cell epithelial-mesenchymal transition (EMT).
Long X; Wang DG; Wu ZB; Liao ZM; Xu JJ
Cancer Med; 2023 Apr; 12(7):8289-8305. PubMed ID: 36530171
[TBL] [Abstract][Full Text] [Related]
28. Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR-1343-3p/Bcl-3 axis through TGFβ/Smad3/EMT signaling.
Ge P; Chen X; Liu J; Jing R; Zhang X; Li H
Mol Carcinog; 2023 Jul; 62(7):1073-1085. PubMed ID: 37132942
[TBL] [Abstract][Full Text] [Related]
29. Circular RNA hsa_circ_0011298 enhances Taxol resistance of non-small cell lung cancer by regulating miR-486-3p/CRABP2 axis.
Wu Y; Xie J; Wang H; Hou S; Feng J
J Clin Lab Anal; 2022 May; 36(5):e24408. PubMed ID: 35396749
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of circ-RAD23B inhibits non-small cell lung cancer progression via the miR-142-3p/MAP4K3 axis.
Zhuang Q; Huang Z; Zhuang W; Hong Y; Huang Y
Thorac Cancer; 2022 Mar; 13(5):750-760. PubMed ID: 35106926
[TBL] [Abstract][Full Text] [Related]
31. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.
Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y
Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291
[TBL] [Abstract][Full Text] [Related]
32. Circ_0078767 suppresses non-small-cell lung cancer by protecting RASSF1A expression via sponging miR-330-3p.
Chen T; Yang Z; Liu C; Wang L; Yang J; Chen L; Li W
Cell Prolif; 2019 Mar; 52(2):e12548. PubMed ID: 30507050
[TBL] [Abstract][Full Text] [Related]
33. Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5).
Wei D; Zeng J; Rong F; Xu Y; Wei R; Zou C
Bioengineered; 2022 Mar; 13(3):5126-5140. PubMed ID: 35170372
[TBL] [Abstract][Full Text] [Related]
34. Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924/SLC1A5 signaling.
Liu Y; Wang S; Pan S; Yan Q; Li Y; Zhao Y
J Clin Lab Anal; 2022 Jan; 36(1):e24116. PubMed ID: 34811815
[TBL] [Abstract][Full Text] [Related]
35. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
Gao P; Wang Z; Hu Z; Jiao X; Yao Y
J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
[TBL] [Abstract][Full Text] [Related]
36. MiR-7-5p suppresses tumor metastasis of non-small cell lung cancer by targeting NOVA2.
Xiao H
Cell Mol Biol Lett; 2019; 24():60. PubMed ID: 31832068
[TBL] [Abstract][Full Text] [Related]
37. Depletion of circ-BIRC6, a circular RNA, suppresses non-small cell lung cancer progression by targeting miR-4491.
Jin Z; Gao B; Gong Y; Guan L
Biosci Trends; 2021 Jan; 14(6):399-407. PubMed ID: 33177288
[TBL] [Abstract][Full Text] [Related]
38. Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non-small-cell lung cancer cells by regulating the miR-526b-5p/GRK5 axis.
Liu Y; Li C; Liu H; Wang J
Pharmacol Res Perspect; 2021 Aug; 9(4):e00812. PubMed ID: 34219377
[TBL] [Abstract][Full Text] [Related]
39. Circ_0006220 Contributes to NSCLC Progression through miR-342-3p/GOT2 Axis.
Tang J; Li X; Zhao L; Hui J; Ding N
Ann Thorac Cardiovasc Surg; 2023 Feb; 29(1):11-22. PubMed ID: 36575008
[TBL] [Abstract][Full Text] [Related]
40. circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC).
Tang YF; Liu ZH; Zhang LY; Shi SH; Xu S; Ma JA; Hu CH; Zou FW
Mol Cancer; 2024 May; 23(1):91. PubMed ID: 38715012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
